Clinical significance of circulating anti-p53 antibodies in European patients with hepatocellular carcinoma (original) (raw)

References

• Akashi, Y., Koreeda, C., Enomoto, S., Uchiyama, S., Mizono, T., Shiozaki, Y., Sameshima, Y. & Inoue, K. (1991). Prognosis of unresectable hepatocellular carcinoma: an evaluation based on multivariate analysis of 90 cases. Hepatology 14: 262–268.
  Article CAS Google Scholar
• Angelopoulou, K., Diamandis, E. P., Sutherland, D. J. A., Kellen, J. A. & Bunting, P. S. (1994). Prevalence of serum antibodies against the p53 tumour suppressor gene protein in various cancers. Int J Cancer 58: 480–487.
  Article CAS Google Scholar
• Angelopoulou, K., Rosen, B., Stratis, M., Yu, H., Solomou, M. & Diamandis, E. P. (1996). Circulating antibodies against p53 protein in patients with ovarian carcinoma. Cancer 15: 2146–2152.
  Article Google Scholar
• Bismuth, H., Morino, M., Sherlock, D., Castaing, D., Miglietta, C., Cauquil, P. & Roche, A. (1992). Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg 163: 387–394.
  Article CAS Google Scholar
• Bismuth, H., Chiche, L., Adam, R., Castaing, D., Diamond, T. & Dennison, A. (1993). Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 218: 145–151.
  Article CAS Google Scholar
• Bourdon, J. C., D’Errico, A., Paterlini, P., Grigioni, W., May, E. & Debuire, B. (1995). p53 protein accumulation in European hepatocellular carcinoma is not always dependent on p53 gene mutation. Gastroenterology 108: 1176–1182.
  Article CAS Google Scholar
• Bourhis, J., Lubin, R., Roche, B., Koscielny, S., Bosq, J., Dubois, I., Talbot, M., Marandas, P., Schwaab, G., Wibault, P., Luboinski, B., Eschwege, F. & Soussi, T. (1996). Analysis of p53 serum antibodies in patients with head and neck squamous cell carcinomas. J Natl Cancer Inst 88: 1228–1233.
  Article CAS Google Scholar
• Challen, C., Lunec, J., Warren, W., Collier, J. & Bassendine, M. F. (1992). Analysis of the p53 tumour-suppressor gene in hepatocellular carcinomas from Britain. Hepatology 16: 1362–1366.
  Article CAS Google Scholar
• Coomber, D., Hawkins, N. J., Clark, M., Meagher, A. & Ward, R. L. (1996). Characterization and clinicopathological correlates of serum anti-p53 antibodies in breast and colon cancer. J Cancer Res Clin Oncol 122: 757–762.
  Article CAS Google Scholar
• Davidoff, A. M., Iglehart, J. D. & Marks, J. R. (1992). Immune response to p53/HSP70 complexes in breast cancers. Proc Natl Acad Sci USA 89: 3439–3442.
  Article CAS Google Scholar
• Debuire, B., Paterlini, P., Pontisso, P., Basso, G. & May, E. (1993). Analysis of the p53 gene in European hepatocellular carcinomas and hepatoblastomas. Oncogene 8: 2303–2306.
  CAS PubMed Google Scholar
• Delphin Cahen, P., Lawrence, J. J. & Baudier, J. (1994). Characterization of baculovirus recombinant wild type p53. Dimerization of p53 is required for high affinity DNA binding and cysteine oxidation inhibits p53 DNA binding. Eur J Biochem 223: 683–692.
  Article CAS Google Scholar
• D’Errico, A., Grigioni, W. F., Fiorentino, M., Baccarini, P., Grazi, G. L. & Mancini, A. M. (1994). Overexpression of p53 protein and Ki67 proliferative index in hepatocellular carcinoma. Pathol Int 44: 682–687.
  Article Google Scholar
• Gadducci, A., Ferdeghini, M., Buttitta, F., Fanucchi, A., Annicchiarico, C., Prontera, C., Bevilacqua, G. & Genazzani, R. (1996). Preoperative serum antibodies against the p53 protein in patients with ovarian endometrial cancer. Anticancer Res 16: 3519–3524.
  CAS PubMed Google Scholar
• Ganne-Carie, N., Chastang, C., Chapel, F., Munz, C., Pateron, D., Sibony, M., Deny, P., Trinchet, J. C., Gallard, P., Guettier, C. & Beaugrand, M. (1996). Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in western patients with cirrhosis. Hepatology 23: 1112–1118.
  Article Google Scholar
• Gansauge, S., Gansauge, F., Negri, G., Galle, P., Mûller, J., Nûssler, A. K., Poch, B. & Beger, H. G. (1996). The role of anti-p53 autoantibodies in pancreatic disorders. Int J Pancreatol 19: 171–178.
  CAS PubMed Google Scholar
• Houbiers, J. G. A., Van Der Burg, S. H., Van De Watering, L. M. G., Tollenaar, RAEM, Brand, A., Van De Velde, C. J. H. & Melief, C. M. J. (1995). Antibodies against p53 are associated with poor prognosis of colorectal cancer. Br J Cancer 72: 637–641.
  Article CAS Google Scholar
• Kaur, J., Srivastava, A. & Ralhan, R. (1997). Serum p53 antibodies in patients with oral lesions: correlation with p53/HSP70 complexes. Int J Cancer 74: 609–613.
  Article CAS Google Scholar
• Kress, S., Jahn, U. R., Buchmann, A., Bannasch, P. & Schwarz, M. (1992). p53 mutations in human hepatocellular carcinomas from Germany. Cancer Res 52: 3220–3223.
  CAS PubMed Google Scholar
• Lechner, M. S. & Laimins, C. A. (1994). Inhibition of p53 binding by human papillomavirus E6 proteins. J Virol 68: 4262–4273.
  CAS PubMed PubMed Central Google Scholar
• Lubin, R., Schlichtholz, B., Teillaud, J. L., Garay, E., Bussel, A., Wild, C. P. & Soussi, T. (1995a). p53 antibodies in patients with various types of cancer: assay, identification, and characterization. Clin Cancer Res 1: 1463–1469.
  CAS PubMed Google Scholar
• Lubin, R., Zalcman, G., Bouchet, L., Tredaniel, J., Legros, Y., Cazals, D., Hirsch, A. & Soussi, T. (1995b). Serum p53 antibodies as early markers of lung cancer. Nature Med 7: 701–702.
  Article Google Scholar
• O’Reilly, D. R. & Miller, L. K. (1988). Expression and complex formation of Simian virus 40 large T antigen and mouse p53 in insect cell. J Virol 62: 3109–3119.
  PubMed PubMed Central Google Scholar
• Raedle, J., Roth, W. K., Oremek, G., Caspary, W. F. & Zeuzem, S. (1995). α-Fetoprotein and p53 autoantibodies in patients with chronic hepatitis C. Dig Dis Sci 40: 2587–2594.
  Article CAS Google Scholar
• Ryder, S. D., Rizzi, P. M., Volkmann, M., Metivier, E., Pereira, L. M. M., Galle, P. R., Naoumov, N. V. & Zentgraf Williams, R. (1996). Use of specific Elisa for the detection of antibodies directed against p53 protein in patients with hepatocellular carcinoma. J Clin Pathol 49: 295–299.
  Article CAS Google Scholar
• Schlichtholz, B., Legros, Y., Gillet, D., Gaillard, C., Marty, M., Lane, D., Calvo, F. & Soussi, T. (1992). The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot. Cancer Res 52: 6380–6384.
  CAS PubMed Google Scholar
• Shiota, G., Kishimoto, Y., Suyama, A., Okubo, M., Katayama, S., Harada, K., Ishida, M., Hori, K., Suou, T. & Kawasaki, H. (1997). Prognostic significance of serum anti-p53 antibody in patients with hepatocellular carcinoma. J Hepatol 27: 661–668.
  Article CAS Google Scholar
• Soussi, T., Legros, Y., Lubin, R., Ory, K. & Schlichtholz, B. (1994). Multifactorial analysis of p53 alteration in human cancer: a review. Int J Cancer 57: 1–9.
  Article CAS Google Scholar
• Trivers, G. E., Cawley, H. L., Debenedetti, V. M. G., Hollstein, M., Marion, M. J., Bennett, W. P., Hoover, M. L., Prives, C. C., Tamburro, C. C. & Harris, C. C. (1995). Anti-p53 antibodies in sera of workers occupationally exposed to vinyl chloride. J Natl Cancer Inst 87: 1400–1407.
  Article CAS Google Scholar
• Trivers, G. E., De Benedetti, V. M. G., Cawley, H. L., Caron, G., Harrington, A. M., Bennett, W. P., Jett, J. R., Colby, T. V., Tazelaar, H., Pairolero, P., Miller, R. & Harris, C. (1996). Anti-p53 antibodies in sera from patients with chronic obstructive pulmonary disease can predate a diagnosis of cancer. Clin Cancer Res 2: 1767–1775.
  CAS PubMed Google Scholar
• Volkmann, M., Müller, M., Hofmann, W. J., Meyer, M., Hagelstein, J., Räth, U., Kommerell, B., Zentgraf, H. & Galle, P. R. (1993). The humoral immune response to p53 in patients with hepatocellular carcinoma is specific for malignancy and independent of the a-fetoprotein status. Hepatology 18: 559–565.
  CAS PubMed Google Scholar
• Wild, C. P., Ridanpaa, M., Anttila, S., Lubin, R., Soussi, T., Husgafvel-Pursiainen, K. & Vainio, H. (1995). p53 antibodies in the sera of lung cancer patients: comparison with p53 mutation in the tumour tissue. Int J Cancer 64: 176–181.
  Article CAS Google Scholar
• Wollenberg, B., Jan, N. V., Pitzke, P., Reiter, W. & Stieber, P. (1997). Anti-p53 antibodies in serum of smokers and head and neck cancer patients. Anticancer Res 17: 413–418.
  CAS PubMed Google Scholar
• Yamashita, Y., Takahashi, M., Koga, Y., Saito, R., Nanakawa, S., Katanaka, Y., Sato, N., Nakashima, K., Urata, J., Yoshizumi, K., Ito, K., Sumi, S. & Kan, M. (1991). Prognostic factors in the treatment of hepatocellular carcinoma with transcatheter arterial embolization and arterial infusion. Cancer 67: 385–391.
  Article CAS Google Scholar
• Zusman, I. (1995). The clinical relevance of p53 oncoprotein determination in cancer diagnosis and prognosis (review). Oncology Rep 2: 143–150.
  CAS Google Scholar

Download references